MDAI Stock Risk & Deep Value Analysis
Spectral AI Inc
Healthcare • Medical Devices
DVR Score
out of 10
What You Need to Know About MDAI Stock
We analyzed Spectral AI Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran MDAI through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
How Risky Is MDAI Stock?
Overall Risk
Aggressive
Financial Risk
High
Market Risk
Medium
Competitive Risk
Medium
Execution Risk
High
Regulatory Risk
Medium
What Are the Red Flags for MDAI?
- ⚠
Failure to secure adequate funding leading to going concern issues or bankruptcy
- ⚠
Delays or unfavorable changes to the BARDA contract
- ⚠
Slower-than-expected commercialization ramp-up and adoption rates
- ⚠
Competitive entrants with similar or superior AI diagnostic technologies
Unlock MDAI Red Flags & Risk Warnings
Create a free account to see the full analysis
What Does Spectral AI Inc (MDAI) Do?
Market Cap
$43.27M
Sector
Healthcare
Industry
Medical Devices
Employees
78
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
Visit Spectral AI Inc WebsiteIs MDAI Stock Undervalued?
Unlock the full AI analysis for MDAI
Get the complete DVR score, risk analysis, and more
Does MDAI Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Expanding
Moat Sources
2 Identified
The moat is primarily built on regulatory approvals (FDA), government validation (BARDA), and proprietary AI algorithms/data, which create significant barriers to entry. As the company scales and integrates into healthcare systems, switching costs for providers will increase, further enhancing durability.
Moat Erosion Risks
- •Emergence of superior AI models from well-funded competitors
- •Failure to secure further regulatory approvals or expand existing ones
- •Challenges in data acquisition and algorithm refinement that could erode technological lead
MDAI Competitive Moat Analysis
Sign up to see competitive advantages
What Could Drive MDAI Stock Higher?
Near-Term (0-6 months)
- •Q4 2025 Earnings Report (Estimated mid-March 2026)
- •Achievement of BARDA contract milestones and associated payments
- •Announcements of initial commercialization partnerships or significant hospital adoptions
Medium-Term (6-18 months)
- •Expansion of BARDA contract scope or new government contracts
- •Additional FDA clearances for new wound types or applications
- •Successful completion of a significant non-dilutive or less dilutive financing round
Long-Term (18+ months)
- •Widespread adoption of AI diagnostics becoming standard of care in wound assessment
- •Establishment of a dominant market position in AI-driven medical diagnostics
- •Potential acquisition by a larger medical device or pharmaceutical company
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for MDAI?
- ✓
Significant progress on BARDA contract deliverables and associated revenue recognition
- ✓
Announcements of new strategic partnerships or major commercial agreements
- ✓
Successful completion of a major financing round that substantially extends cash runway
Bull Case Analysis
See what could go right with Premium
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for MDAI (Spectral AI Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.
